MICHELE WOOTEN: Open Payments
NPI 1114299468 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 75 payments from 21 companies in 2025. Trend: 2023 $2,507 · 2024 $1,912 · 2025 $1,451
Food & beverage: $1,451
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $271 |
| Axsome Therapeutics, Inc. | 7 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $146 |
| ABBVIE INC. | 12 | $144 |
| Viatris Specialty LLC | 5 | $87 |
| Lilly USA, LLC | 4 | $83 |
| Astellas Pharma US Inc | 3 | $63 |
| Novo Nordisk Inc | 3 | $55 |
| Ardelyx, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $45 |
Products named: FARXIGA, Auvelity, CAPLYTA, VRAYLAR, YUPELRI, REXULTI, Veozah, IBSRELA.
Industry payments across NY — which companies pay providers there.
